2023-04-01 2024-03-31 false No description of principal activity Debitam - Tax and Accounts 1.0 13971334 bus:FullAccounts 2023-04-01 2024-03-31 13971334 bus:Micro-entities 2023-04-01 2024-03-31 13971334 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 13971334 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13971334 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13971334 2023-04-01 2024-03-31 13971334 2024-03-31 13971334 bus:RegisteredOffice 2023-04-01 2024-03-31 13971334 core:WithinOneYear 2024-03-31 13971334 core:AfterOneYear 2024-03-31 13971334 2022-03-11 13971334 bus:Director1 2023-04-01 2024-03-31 13971334 bus:Director1 2024-03-31 13971334 bus:Director1 2022-03-11 2023-03-31 13971334 bus:CompanySecretary1 2023-04-01 2024-03-31 13971334 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 13971334 2022-03-11 2023-03-31 13971334 2023-03-31 13971334 core:WithinOneYear 2023-03-31 13971334 core:AfterOneYear 2023-03-31 13971334 bus:EntityAccountantsOrAuditors 2022-03-11 2023-03-31 13971334 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 13971334 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 13971334 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 13971334 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 13971334 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 13971334 core:Non-currentFinancialInstruments 2024-03-31 13971334 core:Non-currentFinancialInstruments 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13971334
England and Wales

 

 

 


Report of the Director and Unaudited Financial Statements

for the year ended 31 March 2024

for

WR PHARMA LTD

 
 
 
£
2024
£
   
£
2023
£
Current assets 80,357  33,493 
Creditors: amount falling due within one year (46,946) (17,046)
Net current assets 33,411  16,447 
Total assets less current liabilities 33,411  16,447 
Accrued liabilities (6,476) (1,234)
Net assets 26,935  15,213 
 
Capital and reserves 26,935  15,213 
 
  1. For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the companies act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Wasim Rafiq
Director

Date approved: 16 October 2024
1
Statutory Information
WR PHARMA LTD is a private limited company, limited by shares, domiciled in England and Wales, registration number 13971334, registration address 340 Blackburn Road, Accrington, BB5 1RZ, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1  (2023: 1).
2